Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | BLM | P54132 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | OGT | O15294 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | RGS12 | O14924 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41583 | 0.97 | TSHR (0.38) | TSHRBLMKDM4EOGTUSP2 | |
| SCHEMBL10514314 | 0.86 | — | — | |
| Acetic Acid SCHEMBL2763491 | 0.84 | HSD17B10 (0.41) | TSHRUSP2MAPTHSD17B10RGS12 | |
| SCHEMBL4551874 | 0.69 | CREBBP (0.54) | KDM4EMAPTHSD17B10LMNAMEN1 | |
| SCHEMBL24742856 | 0.69 | — | — | |
| SCHEMBL10950254 | 0.69 | — | — | |
| SCHEMBL593886 | 0.69 | — | — | |
| Bromide SCHEMBL9542993 | 0.67 | — | — | |
| SCHEMBL367457 | 0.67 | TSHR (0.52) | TSHRBLMKDM4EOGTUSP2 | |
| SCHEMBL2893149 | 0.67 | TSHR (0.39) | TSHRBLMKDM4EOGTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250418-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | HUNTSMAN PETROCHEMICAL LLC | 2025-08-07 | — | — | US | claimed |
| EP-4508111-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | Huntsman Petrochemical LLC (US) | 2025-02-19 | — | — | EP | claimed |
| WO-2023200641-A1 | MIXTURE FOR INHIBITING THE EMISSION OF ALDEHYDES FROM POLYURETHANE FOAM FOR AN EXTENDED PERIOD OF TIME | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-10-19 | — | — | WO | claimed |
| US-11298681-B2 | Urea-impregnated zeolite sorbents and method for making the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-04-12 | — | — | US | claimed |
| US-20210362128-A1 | UREA-IMPREGNATED ZEOLITE SORBENTS AND METHOD FOR MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-11-25 | — | — | US | claimed |
| EP-3758838-A1 | UREA-IMPREGNATED ZEOLITE SORBENTS AND METHOD FOR MAKING THE SAME | 3M Innovative Properties Company (US) | 2021-01-06 | — | — | EP | claimed |
| CN-111818995-A | Urea impregnated zeolite adsorbent and process for preparing same | 3M创新有限公司 | 2020-10-23 | — | — | CN | claimed |
| EP-2988321-B1 | CLEANING LIQUID COMPOSITION | KANTO KAGAKU (JP) | 2019-03-20 | — | — | EP | claimed |
| EP-1387659-B1 | INITIATOR SYSTEM FOR ACID DENTAL FORMULATIONS | 3M ESPE AG (DE) | 2008-05-07 | — | — | EP | claimed |
| US-6554886-B2 | Urea compound and an inorganic acid and/or an organic acid supported on a porous support | KURARAY CHEMICAL CO., LTD. (JP) | 2003-04-29 | — | — | US | claimed |
| CN-1373168-A | thermochromic ink composition | BENQ CORP (CN) | 2002-10-09 | — | — | CN | claimed |
| US-5580681-A | SOLID ELECTROLYTE, ORGANIC ANODE, SOLID CATHODE | E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1996-12-03 | — | — | US | claimed |
| US-3979320-A | Liquid crystal composition | HODOGAYA CHEMICAL CO., LTD. (JA) | 1976-09-07 | — | — | US | claimed |
| JP-9325472-A | — | — | None | — | — | JP | disclosed |
| US-12552882-B2 | Polymeric disinfectants and uses thereof | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2026-02-17 | — | — | US | disclosed |
| US-20260043953-A1 | CHOLESTERIC LIQUID CRYSTAL LAYER, METHOD OF FORMING CHOLESTERIC LIQUID CRYSTAL LAYER, LAMINATE, LIGHT GUIDE ELEMENT, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| WO-1987003313-A1 | BLEACHING PROCESS AND COMPOSITION | QUANTUM TECHNOLOGIES, INC. (US) | 1987-06-04 | — | — | WO | disclosed |
| US-4153601-A | 4-Hydroxyquinolone-(2)-azomethine copper complex pigments | CIBA-GEIGY CORPORATION (US) | 1979-05-08 | — | — | US | disclosed |
| US-3997519-A | Method of producing quaternary pyridinium compounds | GAF CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
| US-3979320-A | Liquid crystal composition | HODOGAYA CHEMICAL CO., LTD. (JA) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043953-A1 | CHOLESTERIC LIQUID CRYSTAL LAYER, METHOD OF FORMING CHOLESTERIC LIQUID CRYSTAL LAYER, LAMINATE, LIGHT GUIDE ELEMENT, AND IMAGE DISPLAY DEVICE | NPC1, NPC1L1, CDCA2 | TSHR 3590/4885BLM 1356/4885KDM4E 3544/4885 |
| US-12552882-B2 | Polymeric disinfectants and uses thereof | PIK3C3, POLR1C, CUTA | TSHR 2788/4885BLM 1155/4885KDM4E 1154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.